ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 83 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,587,495 | -22.0% | 3,568,181 | 0.0% | 14.33% | +33.4% |
| Q2 2023 | $27,689,085 | +36.1% | 3,568,181 | 0.0% | 10.75% | +46.1% |
| Q1 2023 | $20,338,632 | -3.2% | 3,568,181 | 0.0% | 7.35% | +5.1% |
| Q4 2022 | $21,016,586 | +84.1% | 3,568,181 | 0.0% | 7.00% | +176.9% |
| Q3 2022 | $11,418,000 | -28.6% | 3,568,181 | 0.0% | 2.53% | -25.7% |
| Q2 2022 | $15,985,000 | -16.1% | 3,568,181 | 0.0% | 3.40% | -3.7% |
| Q1 2022 | $19,054,000 | -63.7% | 3,568,181 | 0.0% | 3.53% | -50.5% |
| Q4 2021 | $52,452,000 | -47.4% | 3,568,181 | -25.2% | 7.13% | -37.1% |
| Q3 2021 | $99,703,000 | +18.2% | 4,768,181 | 0.0% | 11.34% | -5.0% |
| Q2 2021 | $84,349,000 | -27.8% | 4,768,181 | 0.0% | 11.94% | +6.7% |
| Q1 2021 | $116,820,000 | -27.6% | 4,768,181 | 0.0% | 11.19% | -23.5% |
| Q4 2020 | $161,403,000 | – | 4,768,181 | – | 14.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $161,403,000 | 14.64% |
| Invus Financial Advisors, LLC | 1,007,575 | $34,106,000 | 14.26% |
| Euclidean Capital LLC | 1,400,435 | $47,405,000 | 10.04% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $20,387,000 | 8.63% |
| EcoR1 Capital, LLC | 3,092,218 | $104,672,000 | 5.63% |
| Ally Bridge Group (NY) LLC | 413,061 | $13,982,000 | 2.40% |
| Asymmetry Capital Management, L.P. | 67,210 | $2,275,000 | 1.04% |
| Orbimed Advisors | 2,921,967 | $98,909,000 | 0.86% |
| Casdin Capital, LLC | 601,515 | $20,361,000 | 0.60% |
| EMERALD ADVISERS, LLC | 522,302 | $17,680,000 | 0.59% |